These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7781437)

  • 21. Interferon treatment for hepatitis C virus infection in patients on haemodialysis.
    Chan TM; Wu PC; Lau JY; Lok AS; Lai CL; Cheng IK
    Nephrol Dial Transplant; 1997 Jul; 12(7):1414-9. PubMed ID: 9249778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
    Mochida S; Ohnishi K; Matsuo S; Kakihara K; Fujiwara K
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy of a high or low dose of interferon alpha 2b in chronic hepatitis C: a randomized controlled trial.
    Tassopoulos NC; Karvountzis G; Touloumi G; Delladetsima JK; Papatheodoridis GV; Katsoulidou A; Retalis G; Hatzakis A
    Am J Gastroenterol; 1996 Sep; 91(9):1734-8. PubMed ID: 8792690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study.
    Iino S; Hino K; Kuroki T; Suzuki H; Yamamoto S
    Dig Dis Sci; 1993 Apr; 38(4):612-8. PubMed ID: 8384980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant alpha 2B interferon (IFN) in the treatment of chronic hepatitis C disease in thalassaemia major (TM).
    Wonke B; Donohue SM; Hoffbrand AV; Scheuer PJ; Brown D; Dusheiko G
    Bone Marrow Transplant; 1993; 12 Suppl 1():24-5. PubMed ID: 8397033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year.
    Caporaso N; Suozzo R; Morisco F; D'Antonio M; Romano M; Coltorti M
    Ital J Gastroenterol; 1993; 25(9):482-6. PubMed ID: 8123895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Interferon treatment of chronic hepatitis C: a controlled, multicentre, prospective study.
    Angelini G; Sgarbi D; Colombari R; Bezzi A; Castagnini A; de Berardinis F; Conti A; di Piramo D; Dolci L; Falezza G
    Digestion; 1995; 56(3):199-203. PubMed ID: 7657044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?
    Lin R; Schoeman MN; Craig PI; Bilous M; Grierson J; McDonald JA; Batey RG; Farrell GC
    Aust N Z J Med; 1991 Jun; 21(3):387-92. PubMed ID: 1953524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term prognosis of chronic hepatitis C after treatment with interferon alpha 2b and characterization of incomplete responders.
    Hakozaki Y; Shirahama T; Katou M; Nakagawa K; Oba K; Yoshii O; Matsumoto T; Kuwabara N; Mitamura K
    Am J Gastroenterol; 1996 Oct; 91(10):2144-9. PubMed ID: 8855738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up evaluation in HCV chronic hepatitis treated with alpha-2b interferon. A comparison of two protocols.
    Budillon G; Cimino L; Del Vecchio Blanco C; Mazzacca G; Iaquinto G; D'Ascoli B; Lampasi F; Di Sapio M; Mattera D; Sapio D [corrected to Di Sapio M]
    Ital J Gastroenterol; 1994; 26(1):16-20. PubMed ID: 8025301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination treatment of advanced HCV associated liver disease with interferon and G-CSF.
    Van Thiel DH; Faruki H; Friedlander L; Fagiuoli S; Caraceni P; Molloy PJ; Kania RJ; Wright HI
    Hepatogastroenterology; 1995; 42(6):907-12. PubMed ID: 8847044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of interferon combined glycyrrhizin therapy in patients with chronic hepatitis C resistant to interferon therapy].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1994 Jul; 52(7):1823-7. PubMed ID: 8078202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alpha-interferon 2b in the treatment of chronic hepatitis C: interim report of the first multicentre Australian trial.
    Lin R; Liddle C; Farrell GC
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():101-3. PubMed ID: 8359618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up.
    Bresci G; Parisi G; Banti S; Bertoni M
    Eur J Med; 1993; 2(6):349-52. PubMed ID: 8252180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant interferon alfa-2b treatment in chronic non-A, non-B/type C hepatitis.
    De Conca V; Mesiti S; Vallarino E; Mornese A; Dodero M
    Gut; 1993; 34(2 Suppl):S126. PubMed ID: 8314477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
    Métreau JM
    Gut; 1993; 34(2 Suppl):S112-3. PubMed ID: 8314474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a].
    Hopf U; Küther S; König V; Heuft H; Berg T; Bauditz J; Soltani K; Lobeck H; Huhn D
    Z Gastroenterol; 1994 Aug; 32(8):425-30. PubMed ID: 7975783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-transfusion etiology and non-cirrhotic histology improve the remission rate of chronic hepatitis C during interferon treatment.
    Halpern Z; Arber N; Hallak A; Konikoff F; Santo M; Moshkowitz M; Tomny E; Gilat T
    Isr J Med Sci; 1995 Jun; 31(6):341-4. PubMed ID: 7607851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.